• FEBUXOSTAT CHEMBL1164729 FDA Approved

    Alternate Names:

    Febuxostat
    Adenuric
    TMX-67
    Uloric
    2-?[3-?CYANO-?4-?(2-?METHYLPROPOXY)PHENYL]-?4-?METHYL-?5-?THIAZOLECARBOXYLIC ACID
    2-(3-CYANO-4-ISOBUTOXY-PHENYL)-4-METHYL-THIAZOLE-5-CARBOXYLIC ACID
    Q-100164
    3B2-1576
    AB01274796-01
    Q-4339
    ST24027508
    FT-0601639
    F0847
    AM20090760
    TC-070914
    AB2000143
    AB0005158
    SC-20178
    S033
    HY-14268
    HE111675
    DR001370
    BC220527
    AK-83533
    NCGC00182059-03
    FEBUXOSTAT-SUPPLIED BY SELLECK CHEMICALS
    RTC-070914
    RP17652
    PB33929
    NSC-758874
    MCULE-6974079178
    CS-0403
    CCG-213303
    BS-1018
    BCP9000679
    TOX21_113004_1
    AKOS015841695
    NSC758874
    FD7322
    FC0017
    DAP001444
    BDBM50320491
    ANW-46040
    AN-608
    ABP000399
    TOX21_113004
    ACT06289
    ACN-S001482
    PHARMAKON1600-01504286
    HMS3264C20
    BCPP000233
    101V0R1N2E
    CHEBI:747206
    BQSJTQLCZDPROO-UHFFFAOYSA-N
    CTK8B4748
    CHEBI:45943
    ZINC5423
    GTPL6817
    SCHEMBL249339
    FEBUXOSTAT [USAN:INN:BAN]
    MLS006011568
    MLS004774136
    FEBUXOSTAT,ULORIC, TMX-67
    ADENURIC, ULORIC , FEBUTAZ
    FEBUXOSTAT(TEI 6720)
    TMX-67;ADENURIC;ULORIC
    FEBUXOSTAT(ULORIC) /
    ULORIC (TN)
    CID134018
    FEBURIC (TN)
    2-[3-CYANO-4-ISOBUTOXYPHENYL]-4-METHYLTHIAZOLE-5-CARBOXYLIC ACID
    FEBRIC
    ULORICREG
    FEBURIC
    ADENURICREG
    CAS-144060-53-7
    SMR002529566
    FBX
    2-[3-CYANO-4-(2-METHYLPROPOXY)PHENYL]-4-METHYL-5-THIAZOLECARBOXYLIC ACID
    TEI
    DSSTOX_GSID_48650
    DSSTOX_RID_82848
    DSSTOX_CID_28576
    D01206
    2-(3-CYANO-4-(2-METHYLPROPOXY)PHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLIC ACID
    S1547
    FT-0081351
    LS-173202
    111GE013
    NCGC00182059-02
    TMX-67, ADENURIC, ULORIC, FEBUXOSTAT
    DB03786
    AC-425
    5-THIAZOLECARBOXYLIC ACID, 2-[3-CYANO-4-(2-METHYLPROPOXY)PHENYL]-4-METHYL-
    5-THIAZOLECARBOXYLIC ACID, 2-(3-CYANO-4-(2-METHYLPROPOXY)PHENYL)-4-METHYL-
    2-(3-CYANO-4-ISOBUTOXY-PHENYL)-4-METHYL-5-THIAZOLE-CARBOXYLIC ACID
    MX-67
    MOLPORT-005-940-740
    2-(3-CYANO-4-ISOBUTOXYPHENYL)-4-METHYL-5-THIAZOLECARBOXYLIC ACID
    FEBUXOSTAT (JAN/USAN/INN)
    2-[3-CYANO-4-(2-METHYLPROPOXY)PHENYL]-4-METHYL-1,3-THIAZOLE-5-CARBOXYLIC ACID
    AC1L33UC
    C16H16N2O3S
    S1547_SELLECK
    FEBUXOSTAT [USAN]
    UNII-101V0R1N2E
    TEI-6720
    2-(3-CYANO-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLIC ACID
    TMX 67
    TEI 6720
    144060-53-7
    134018
    J10392
    FEBUXOSTAT;
    Barif
    Atenurix
    2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid
    DB04854
    12014717

    Drug Info:

    Year of Approval 2009
    Drug Class gout suppressants
    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications for treatment of gout
    Drug Categories xanthine oxidase inhibitors inhibitors
    Drug Categories thiazoles
    Drug Categories therapeutic uses
    Drug Categories sulfur compounds
    Drug Categories preparations inhibiting uric acid production
    Drug Categories pharmacologic actions
    Drug Categories organic chemicals
    Drug Categories musculo-skeletal system
    Drug Categories inorganic chemicals
    Drug Categories heterocyclic compounds, 1-ring
    Drug Categories heterocyclic compounds
    Drug Categories gout suppressants
    Drug Categories chemical actions and uses
    Drug Categories azoles
    Drug Categories antirheumatic agents
    Drug Categories antigout preparations
    Drug Groups approved
    Drug Type small molecule
    (2 More Sources)
    • Version: 5.0.8

    Alternate Names:
    FEBUXOSTAT DrugBank Drug Name
    2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid Drug Synonym
    144060-53-7 CAS Number

    Drug Info:
    Drug Type small molecule
    Drug Groups approved
    Drug Categories antigout preparations

    • Version: 01-August-2011

    Alternate Names:
    FEBUXOSTAT Primary Drug Name

    Drug Info:
    Drug Class gout suppressants
    Year of Approval 2009

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications for treatment of gout
    Drug Class Small molecule
    FDA Approval not approved

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    FEBUXOSTAT; Drug Synonym
    J10392 Drug Synonym
    FEBUXOSTAT pubchem_primary_name

    Drug Info:

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    AC-425 Drug Synonym
    D01206 Drug Synonym
    2-(3-CYANO-4-ISOBUTOXYPHENYL)-4-METHYL-5-THIAZOLECARBOXYLIC ACID Drug Synonym

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: